Paper42717153
Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.
Lipton RB and 10 others. Neurol Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE. Papers, record 42717153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42717153
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06467370 | A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults. | Derived from the trial | Yes |
Source ClinicalTrials.gov
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39661241 | The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. | Pain Ther | 2025 | https://conductscience.org/library/papers/39661241 | PubMed |
| 2 | 39262214 | International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine. | Cephalalgia | 2024 | https://conductscience.org/library/papers/39262214 | PubMed |
| 3 | 34160823 | The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. | Headache | 2021 | https://conductscience.org/library/papers/34160823 | PubMed |
| 4 | 38466028 | Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. | Headache | 2024 | https://conductscience.org/library/papers/38466028 | PubMed |
| 5 | 40663598 | Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns. | Headache | 2025 | https://conductscience.org/library/papers/40663598 | PubMed |
| 6 | 39404951 | What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle. | Neurol Ther | 2024 | https://conductscience.org/library/papers/39404951 | PubMed |
| 7 | 41721442 | Unmet treatment needs in migraine: Results of the OVERCOME (US) study. | Headache | 2026 | https://conductscience.org/library/papers/41721442 | PubMed |
| 8 | 40238598 | Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment. | Pain Manag | 2025 | https://conductscience.org/library/papers/40238598 | PubMed |
| 9 | 26252585 | Preventive Migraine Treatment. | Continuum (Minneap Minn) | 2015 | https://conductscience.org/library/papers/26252585 | PubMed |
| 10 | 37208596 | The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. | J Headache Pain | 2023 | https://conductscience.org/library/papers/37208596 | PubMed |
| 11 | 35027572 | Migraine. | Nat Rev Dis Primers | 2022 | https://conductscience.org/library/papers/35027572 | PubMed |
| 12 | 31020659 | Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class. | Headache | 2019 | https://conductscience.org/library/papers/31020659 | PubMed |
| 13 | 42288801 | Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial. | J Headache Pain | 2026 | https://conductscience.org/library/papers/42288801 | PubMed |
| 14 | 39762740 | Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study). | J Headache Pain | 2025 | https://conductscience.org/library/papers/39762740 | PubMed |
| 15 | 39333875 | First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients. | J Headache Pain | 2024 | https://conductscience.org/library/papers/39333875 | PubMed |
| 16 | 41204073 | Patient-reported outcomes of rimegepant for acute and preventive treatment of migraine in China: a prospective, multicenter, real-world study. | J Headache Pain | 2025 | https://conductscience.org/library/papers/41204073 | PubMed |
| 17 | 39766367 | Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study. | Brain Sci | 2024 | https://conductscience.org/library/papers/39766367 | PubMed |
| 18 | 17062301 | Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies. | Clin Ther | 2006 | https://conductscience.org/library/papers/17062301 | PubMed |
| 19 | 20869152 | Controlled phase III clinical trial of diclofenac potassium liquid-filled soft gelatin capsule for treatment of postoperative dental pain. | J Oral Maxillofac Surg | 2010 | https://conductscience.org/library/papers/20869152 | PubMed |
| 20 | 24631409 | Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort. | Eur Urol | 2015 | https://conductscience.org/library/papers/24631409 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42717153
GET https://conductscience.org/api/papers/v1/42717153/references?page=2